The Hong Kong Stock Exchange's latest filings reveal that on July 29, The Capital Group Companies, Inc. added to its position in HENGRUI PHARMA (01276) by acquiring 483,600 shares.
The transaction was executed at an average price of HK$57.9041 per share, bringing the total investment to roughly HK$28.0024 million.
Following this purchase, The Capital Group Companies now holds a total of approximately 25.933 million shares in the company, representing a 10.04% stake in the pharmaceutical firm.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments